Low-dose radioimmunotherapy ((90)Y-PAM4) combined with gemcitabine for the treatment of experimental pancreatic cancer.

Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease

1959 • 14,850 citations

Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study.

1998 • 348 citations

Phase I Trial of Radiation Dose Escalation With Concurrent Weekly Full-Dose Gemcitabine in Patients With Advanced Pancreatic Cancer

2001 • 316 citations

Phase I Trial of Twice-Weekly Gemcitabine and Concurrent Radiation in Patients With Advanced Pancreatic Cancer

1999 • 243 citations

Metabolism of 2',2'-difluoro-2'-deoxycytidine and radiation sensitization of human colon carcinoma cells.

1994 • 229 citations

High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma

2002 • 214 citations

Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma.

1998 • 189 citations

Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas

2001 • 168 citations

Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer

2002 • 159 citations

Radiation Concurrent With Gemcitabine for Locally Advanced Head and Neck Cancer: A Phase I Trial and Intracellular Drug Incorporation Study

2001 • 147 citations

Gemcitabine-mediated radiosensitization.

1997 • 133 citations

Eastern Cooperative Oncology Group Phase I Trial of Protracted Venous Infusion Fluorouracil Plus Weekly Gemcitabine With Concurrent Radiation Therapy in Patients With Locally Advanced Pancreas Cancer: A Regimen With Unexpected Early Toxicity

2000 • 126 citations

Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer

2002 • 118 citations

Radioimmunotherapy of small-volume disease of metastatic colorectal cancer

2002 • 113 citations

Construction and characterization of a humanized, internalizing, B-cell (CD22)-specific, leukemia/lymphoma antibody, LL2

1995 • 109 citations

Antitumor activity of prolonged as compared with bolus administration of 2′,2′-difluorodeoxycytidine in vivo against murine colon tumors

1996 • 98 citations

Low-dose, Fractionated Radioimmunotherapy for B-cell Malignancies using¹³¹I-LYM-1 Antibody

1998 • 97 citations

90Y-DOTA-hLL2: an agent for radioimmunotherapy of non-Hodgkin's lymphoma.

2003 • 81 citations

Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study

2000 • 72 citations

Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and ⁹⁰yttrium‐DOTA‐peptide‐ChL6

2001 • 69 citations

Characterization of monoclonal antibody PAM4 reactive with a pancreatic cancer mucin

1994 • 66 citations

Radioimmunotherapy of a human lung cancer xenograft with monoclonal antibody RS7: evaluation of (177)Lu and comparison of its efficacy with that of (90)Y and residualizing (131)I.

2001 • 63 citations

Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma.

1998 • 61 citations

Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinoma

1997 • 59 citations

Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.

2000 • 57 citations

Single-dose versus fractionated radioimmunotherapy: model comparisons for uniform tumor dosimetry.

2000 • 52 citations

Therapeutic advantage of (90)yttrium- versus (131)iodine-labeled PAM4 antibody in experimental pancreatic cancer.

2001 • 46 citations

Combined modality radioimmunotherapy

2002 • 40 citations

On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer

2002 • 39 citations

Combining radioimmunotherapy and chemotherapy for treatment of medullary thyroid carcinoma

2001 • 38 citations

Localization of pancreatic cancer with radiolabeled monoclonal antibody PAM4

2001 • 36 citations

⁹⁰Yttrium-Labeled Complementarity-Determining-Region-Grafted Monoclonal Antibodies for Radioimmunotherapy: Radiolabeling and Animal Biodistribution Studies

1998 • 32 citations

Targeting of xenografted pancreatic cancer with a new monoclonal antibody, PAM4.

1995 • 31 citations

Combined Modality Radioimmunotherapy with Taxol and ⁹⁰Y-LYM-1 for Raji Lymphoma Xenografts

1998 • 30 citations

Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: development of a clinical protocol.

1999 • 27 citations

Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts.

2001 • 22 citations

Efficacy, toxicity and mode of interaction of combination radioimmunotherapy with 5-fluorouracil in colon cancer xenografts

1999 • 21 citations

Assessment of combined radioimmunotherapy and chemotherapy for treatment of medullary thyroid cancer.

1999 • 14 citations

Enhanced Efficacy of Radioimmunotherapy Combined with Systemic Chemotherapy and Local Hyperthermia in Xenograft Model

2000 • 10 citations

Relationship between cell kinetics and radiation-induced arrest of proliferating cells in G2: relevance to efficacy of radiotherapy.

1989 • 7 citations